Dian Diagnostics Group Co.,Ltd. (300244.SZ)
CNY 13.69
(-0.73%)
CNY 13.69
(-0.73%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 1.86 Billion CNY | -61.21% |
| 2022 | 3.69 Billion CNY | 65.44% |
| 2021 | 2.51 Billion CNY | 17.69% |
| 2020 | 1.88 Billion CNY | 64.56% |
| 2019 | 1.23 Billion CNY | 21.36% |
| 2018 | 1.08 Billion CNY | 30.62% |
| 2017 | 846.28 Million CNY | 68.22% |
| 2016 | 512.22 Million CNY | 98.0% |
| 2015 | 260.42 Million CNY | 48.16% |
| 2014 | 180.19 Million CNY | 35.61% |
| 2013 | 133.83 Million CNY | 49.4% |
| 2012 | 88.18 Million CNY | 54.69% |
| 2011 | 58.45 Million CNY | 27.52% |
| 2010 | 45.83 Million CNY | 58.24% |
| 2009 | 28.34 Million CNY | 110.12% |
| 2008 | 13.31 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 364.09 Million CNY | 42.3% |
| 2024 Q1 | 257.8 Million CNY | 200.58% |
| 2024 Q3 | 236.65 Million CNY | -35.49% |
| 2023 FY | - CNY | -61.21% |
| 2023 Q3 | 392.97 Million CNY | -36.66% |
| 2023 Q2 | 620.44 Million CNY | 16.17% |
| 2023 Q4 | 85.76 Million CNY | -78.17% |
| 2023 Q1 | 534.09 Million CNY | 1807.75% |
| 2022 Q3 | 946.77 Million CNY | -43.54% |
| 2022 Q1 | 1.22 Billion CNY | 240.81% |
| 2022 FY | - CNY | 65.44% |
| 2022 Q4 | -31.27 Million CNY | -103.3% |
| 2022 Q2 | 1.67 Billion CNY | 37.17% |
| 2021 FY | - CNY | 17.69% |
| 2021 Q1 | 564.7 Million CNY | 1.68% |
| 2021 Q4 | 358.7 Million CNY | -56.93% |
| 2021 Q3 | 832.79 Million CNY | 54.73% |
| 2021 Q2 | 538.21 Million CNY | -4.69% |
| 2020 Q2 | 745.37 Million CNY | 563.72% |
| 2020 Q4 | 555.39 Million CNY | -16.35% |
| 2020 FY | - CNY | 64.56% |
| 2020 Q3 | 663.95 Million CNY | -10.92% |
| 2020 Q1 | 112.3 Million CNY | -65.41% |
| 2019 Q4 | 324.63 Million CNY | 23.45% |
| 2019 FY | - CNY | 21.36% |
| 2019 Q1 | 225.29 Million CNY | -29.97% |
| 2019 Q2 | 379.53 Million CNY | 68.46% |
| 2019 Q3 | 262.97 Million CNY | -30.71% |
| 2018 Q2 | 311.02 Million CNY | 113.59% |
| 2018 Q1 | 145.61 Million CNY | -52.22% |
| 2018 Q3 | 235.55 Million CNY | -24.26% |
| 2018 Q4 | 321.69 Million CNY | 36.57% |
| 2018 FY | - CNY | 30.62% |
| 2017 Q1 | 109.39 Million CNY | -39.49% |
| 2017 Q3 | 171.56 Million CNY | -28.92% |
| 2017 Q4 | 304.78 Million CNY | 77.65% |
| 2017 FY | - CNY | 68.22% |
| 2017 Q2 | 241.36 Million CNY | 120.64% |
| 2016 FY | - CNY | 98.0% |
| 2016 Q4 | 180.77 Million CNY | 75.91% |
| 2016 Q3 | 102.76 Million CNY | -36.94% |
| 2016 Q2 | 162.96 Million CNY | 216.33% |
| 2016 Q1 | 51.51 Million CNY | -40.85% |
| 2015 Q3 | 47.01 Million CNY | -46.17% |
| 2015 Q4 | 87.09 Million CNY | 85.24% |
| 2015 Q1 | 25.39 Million CNY | -30.54% |
| 2015 FY | - CNY | 48.16% |
| 2015 Q2 | 87.33 Million CNY | 243.9% |
| 2014 Q3 | 37.48 Million CNY | -38.34% |
| 2014 FY | - CNY | 35.61% |
| 2014 Q1 | 23.41 Million CNY | -35.05% |
| 2014 Q2 | 60.78 Million CNY | 159.58% |
| 2014 Q4 | 36.56 Million CNY | -2.46% |
| 2013 Q4 | 36.05 Million CNY | 59.37% |
| 2013 FY | - CNY | 49.4% |
| 2013 Q1 | 16.74 Million CNY | -45.59% |
| 2013 Q2 | 43.12 Million CNY | 157.56% |
| 2013 Q3 | 22.62 Million CNY | -47.55% |
| 2012 Q2 | 24.08 Million CNY | 87.49% |
| 2012 Q4 | 30.77 Million CNY | 195.11% |
| 2012 Q3 | 10.42 Million CNY | -56.7% |
| 2012 Q1 | 12.84 Million CNY | -31.61% |
| 2012 FY | - CNY | 54.69% |
| 2011 Q4 | 18.78 Million CNY | 226.63% |
| 2011 FY | - CNY | 27.52% |
| 2011 Q2 | 17.16 Million CNY | 77.99% |
| 2011 Q1 | 9.64 Million CNY | -22.67% |
| 2011 Q3 | 5.75 Million CNY | -66.49% |
| 2010 Q1 | 8.24 Million CNY | 0.0% |
| 2010 Q4 | 12.47 Million CNY | 56.54% |
| 2010 Q3 | 7.96 Million CNY | -23.09% |
| 2010 Q2 | 10.35 Million CNY | 25.62% |
| 2010 FY | - CNY | 58.24% |
| 2009 FY | - CNY | 110.12% |
| 2008 FY | - CNY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Hangzhou Tigermed Consulting Co., Ltd. | 2.84 Billion CNY | 34.649% |
| Dirui Industrial Co.,Ltd. | 288.83 Million CNY | -544.039% |
| Beijing Strong Biotechnologies, Inc. | 697.99 Million CNY | -166.513% |
| Medicalsystem Biotechnology Co., Ltd. | 475.01 Million CNY | -291.617% |
| Maccura Biotechnology Co.Ltd | 651.98 Million CNY | -185.318% |
| Guangzhou Wondfo Biotech Co.,Ltd | 859.12 Million CNY | -116.525% |
| Guangdong Hybribio Biotech Co.,Ltd. | 236.08 Million CNY | -687.96% |
| BGI Genomics Co., Ltd. | 714.86 Million CNY | -160.222% |
| Amoy Diagnostics Co., Ltd. | 352.59 Million CNY | -427.579% |
| Shanghai Labway Clinical Laboratory Co., Ltd. | -59 Million CNY | 3252.443% |